Right Ventricular Haemodynamic Evaluation and Response to Treatment

NCT ID: NCT03403868

Last Updated: 2020-12-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-01-01

Study Completion Date

2021-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Mono-center Study to evaluate different multimodal functional parameter of the right ventricle in PAH-patients

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Mono-center-study tu evaluate functional parameters in cardiac MRI, conductance catheter (pressure-volume-loops), echocardiography and right heart catheter in PAH patients and to compare different multimodal parameters

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Right Ventricular Dysfunction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Conductance catheter

Contractility-measurement with conductance catheter (pressure-volume-catheter)

Group Type OTHER

conductance catheter

Intervention Type DIAGNOSTIC_TEST

pressure volume loops are assessed via a special catheter (Conductance catheter)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

conductance catheter

pressure volume loops are assessed via a special catheter (Conductance catheter)

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* PH Nizza group 1 and patients without pulmonary hypertension after having the right heart catheter on clinical grounds
* ability to sign informed consent
* male and female between 18 to 85 years
* haemodynamic criteria:

* Pulmonary vascular resistance (PVR) \> 240 dyn x sec x cm-5
* Mean Pulmonary artery pressure (mPAP) ≥ 25 mmHg for PAH patients
* normal haemodynamic in controls
* therapy-naive or at least since two months stabil therapy with approved drugs for PAH (Sildenafil, Tadalafil, Macitentan, Ambrisentan, Bosentan, Iloprost, Treprostinil, Riociguat).

Exclusion Criteria

* therapy with positive inotropic drugs (dobutamin etc.)
* missing informed consent
* pregnancy or lactation
Minimum Eligible Age

18 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

German Research Foundation

OTHER

Sponsor Role collaborator

University of Giessen

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jan Grimminger

Principle Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University hospital Giessen

Giessen, , Germany

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Germany

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Khodr Tello, MD

Role: CONTACT

Phone: 004964198556087

Email: [email protected]

Manuel Richter, MD

Role: CONTACT

Phone: 004964198556022

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Khodr Tello, MD

Role: primary

Manuel Richter, MD

Role: backup

References

Explore related publications, articles, or registry entries linked to this study.

Kremer N, Rako Z, Douschan P, Gall H, Ghofrani HA, Grimminger F, Guth S, Naeije R, Rieth A, Schulz R, Seeger W, Tedford RJ, Vadasz I, Vanderpool R, Wiedenroth CB, Richter MJ, Tello K. Unmasking right ventricular-arterial uncoupling during fluid challenge in pulmonary hypertension. J Heart Lung Transplant. 2022 Mar;41(3):345-355. doi: 10.1016/j.healun.2021.11.019. Epub 2021 Dec 5.

Reference Type DERIVED
PMID: 34972609 (View on PubMed)

Tello K, Wan J, Dalmer A, Vanderpool R, Ghofrani HA, Naeije R, Roller F, Mohajerani E, Seeger W, Herberg U, Sommer N, Gall H, Richter MJ. Validation of the Tricuspid Annular Plane Systolic Excursion/Systolic Pulmonary Artery Pressure Ratio for the Assessment of Right Ventricular-Arterial Coupling in Severe Pulmonary Hypertension. Circ Cardiovasc Imaging. 2019 Sep;12(9):e009047. doi: 10.1161/CIRCIMAGING.119.009047. Epub 2019 Sep 10.

Reference Type DERIVED
PMID: 31500448 (View on PubMed)

Tello K, Dalmer A, Vanderpool R, Ghofrani HA, Naeije R, Roller F, Seeger W, Wilhelm J, Gall H, Richter MJ. Cardiac Magnetic Resonance Imaging-Based Right Ventricular Strain Analysis for Assessment of Coupling and Diastolic Function in Pulmonary Hypertension. JACC Cardiovasc Imaging. 2019 Nov;12(11 Pt 1):2155-2164. doi: 10.1016/j.jcmg.2018.12.032. Epub 2019 Mar 13.

Reference Type DERIVED
PMID: 30878422 (View on PubMed)

Tello K, Dalmer A, Axmann J, Vanderpool R, Ghofrani HA, Naeije R, Roller F, Seeger W, Sommer N, Wilhelm J, Gall H, Richter MJ. Reserve of Right Ventricular-Arterial Coupling in the Setting of Chronic Overload. Circ Heart Fail. 2019 Jan;12(1):e005512. doi: 10.1161/CIRCHEARTFAILURE.118.005512.

Reference Type DERIVED
PMID: 30616360 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

108/15

Identifier Type: -

Identifier Source: org_study_id